TenSixteen Bio
tensixteen.bio
San Francisco, United States · Founded 2021 · $40.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- tensixteen.bio
- Total Funding
- $40.0M
- Last Round
- $40.0M Series AJan 2022
- Rounds
- 1
About
Precision platform therapeutics company targeting somatic mosaicism and DNA changes across multiple disease areas.
Summary
TenSixteen Bio is a Biotech company based in San Francisco, United States, founded in 2021. It has raised $40.0M in total across 1 round, most recently a $40.0M Series A round in Jan 2022. Investors include Foresite Capital and GV.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Jan 2022
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/tensixteen-bio"><img src="https://indexed.vc/api/badge/company/tensixteen-bio" alt="TenSixteen Bio on Indexed.vc" width="260" height="76" /></a>